Related references
Note: Only part of the references are listed.Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/-Catenin Pathways
Zhi-Yu Song et al.
CANCER INVESTIGATION (2018)
Glucagon-like peptide-1 receptor expression in the human eye
Josephine B. Hebsgaard et al.
DIABETES OBESITY & METABOLISM (2018)
Retinal vasculature development in health and disease
Senthil Selvam et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling
Friederike Remm et al.
STEM CELLS INTERNATIONAL (2018)
Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond
Hans-Peter Hammes
DIABETOLOGIA (2018)
Synergic effects of VEGF-A and SDF-1 on the angiogenic properties of endothelial progenitor cells
Gabriela Odent (Grigorescu) et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2017)
SEMA3A partially reverses VEGF effects through binding to neuropilin-1
Bruna Palodetto et al.
STEM CELL RESEARCH (2017)
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Elia J. Duh et al.
JCI INSIGHT (2017)
Type 2 diabetes and quality of life
Aikaterini Trikkalinou et al.
WORLD JOURNAL OF DIABETES (2017)
Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro
Xian-wei Wang et al.
ACTA PHARMACOLOGICA SINICA (2016)
Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together
Xianwei Wang et al.
CLINICAL SCIENCE (2016)
DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization
Fen Zhuge et al.
DIABETES (2016)
Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice
Hotimah Masdan Salim et al.
VASCULAR PHARMACOLOGY (2016)
The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy
Nadine Dietrich et al.
PLOS ONE (2016)
Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation
Choon-Soo Lee et al.
SCIENTIFIC REPORTS (2016)
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
Vladimer Darsalia et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cellmodel for evaluating the selectivity of DPP4 inhibitors
Yi Huan et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2015)
Microglia and Interleukin-1 in Ischemic Retinopathy Elicit Microvascular Degeneration Through Neuronal Semaphorin-3A
Jose Carlos Rivera et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Neuron-Derived Semaphorin 3A Is an Early Inducer of Vascular Permeability in Diabetic Retinopathy via Neuropilin-1
Agustin Cerani et al.
CELL METABOLISM (2013)
Regulation of angiogenesis by PI3K signaling networks
Mariona Graupera et al.
EXPERIMENTAL CELL RESEARCH (2013)
VEGFR and Type-V RTK Activation and Signaling
Masabumi Shibuya
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Diabetic Retinopathy: Targeting Vasoregression
Hans-Peter Hammes et al.
DIABETES (2011)
Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8
Katerina Ajami et al.
FEBS LETTERS (2008)
Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors - good or evil?
Petr Busek et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors
Leo Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization
Raquel Lima e Silva et al.
FASEB JOURNAL (2007)
Management of diabetic retinopathy - A systematic review
Quresh Mohamed et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Retinal angiogenesis in development and disease
RF Gariano et al.
NATURE (2005)
Share Paper
